The Asia Pacific Forensic Genomics Market would witness market growth of 15.0% CAGR during the forecast period (2022-2028).
DNA technologies use Polymerase Chain Reaction (PCR), which is crucial for genetic fingerprinting. DNA testing using PCR is quick and inexpensive, and as crimes increase, there will likely be an increase in demand for these services. Due to an increase in criminal activity, accurate and effective forensic recognition has become essential.
Due to these characteristics, the adoption of biometric analysis is anticipated to increase significantly. The biometric analysis gives an extremely precise analysis of a person as it depends on behavioral and physiological variables. Government investments in judicial and law enforcement systems are expanding, which is leading to a rise in the use of forensic technology to address complex crimes.
The proper diagnosis of individuals with high-risk genetic defects and the accurate identification of rare monogenic illnesses are made possible by genomic technologies. Targeted therapy uses genetic information to improve the precision and focus of the treatment. Prior to the development of genetic technology, prenatal genetic screening put the pregnancy at risk. However, by utilizing maternal blood tests, the process has become more direct.
Key market participants are taking several efforts that are fueling market expansion. For instance, the National Forensic Sciences University and Thermo Fisher Scientific worked together to establish the Centre of Excellence (CoE) for DNA Forensics in Gujrat, India. End-to-end workflows are present across the facility and are supported by cutting-edge technology. In a similar vein, Gene by Gene and Verogen also attempted to hasten the adoption of forensic investigative genetic genealogy.
The China market dominated the Asia Pacific Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $83.3 Million by 2028.The Japan market is estimated to grow a CAGR of 14.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.7% during (2022 - 2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments covered in the Report:
• Criminal Testing
• Paternity & Familial Testing
• Kits & Consumables
• Analyzers & Sequencers
• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification
• South Korea
• Rest of Asia Pacific
• General Electric (GE) Co. (GE Healthcare)
• Eurofins Scientific Group (Eurofins Discovery)
• Gene by Gene, Ltd.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Neogen Corporation
• Thermo Fisher Scientific, Inc.
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free